Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04962737 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-invasive Neuromodulation NESA Through Somatosensory Evoked Potentials and Sympathetic-cutaneous Responses

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 22, 2025 (before its estimated April 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: May 28, 2025 to Nov 28, 2025
    • Primary completion date: Nov 15, 2025 to Apr 15, 2026
    • Study completion date: Mar 20, 2026 to Oct 20, 2026
    v18
  2. Primary completion date: Apr 15, 2025 to Nov 15, 2025
    • Start date: Oct 28, 2024 to May 28, 2025
    • Study completion date: Nov 20, 2025 to Mar 20, 2026
    v17
  3. Start date: Jun 28, 2024 to Oct 28, 2024
    • Primary completion date: Nov 15, 2024 to Apr 15, 2025
    • Study completion date: Apr 20, 2025 to Nov 20, 2025
    v16
  4. Start date: Mar 28, 2024 to Jun 28, 2024
    • Primary completion date: Aug 15, 2024 to Nov 15, 2024
    • Study completion date: Dec 20, 2024 to Apr 20, 2025
    v15
  5. Start date: Nov 28, 2023 to Mar 28, 2024
    • Primary completion date: Mar 15, 2024 to Aug 15, 2024
    • Study completion date: Aug 20, 2024 to Dec 20, 2024
    v14
Show 12 earlier versionsHide 12 earlier versions
  1. Start date: Sep 28, 2023 to Nov 28, 2023
    • Primary completion date: Dec 15, 2023 to Mar 15, 2024
    v13
  2. Start date: May 28, 2023 to Sep 28, 2023
    • Primary completion date: Jul 15, 2023 to Dec 15, 2023
    • Study completion date: Nov 20, 2023 to Aug 20, 2024
    v12
  3. Start date: Feb 28, 2023 to May 28, 2023
    • Primary completion date: Mar 15, 2023 to Jul 15, 2023
    • Study completion date: Jun 20, 2023 to Nov 20, 2023
    v11
  4. Start date: Nov 28, 2022 to Feb 28, 2023
    • Primary completion date: Dec 15, 2022 to Mar 15, 2023
    • Study completion date: Mar 20, 2023 to Jun 20, 2023
    v10
  5. Start date: Jun 28, 2022 to Nov 28, 2022
    • Primary completion date: Sep 15, 2022 to Dec 15, 2022
    • Study completion date: Dec 20, 2022 to Mar 20, 2023
    v9
  6. Start date: Apr 28, 2022 to Jun 28, 2022
    • Primary completion date: May 15, 2022 to Sep 15, 2022
    • Study completion date: Oct 20, 2022 to Dec 20, 2022
    v8
  7. Start date: Feb 28, 2022 to Apr 28, 2022
    • Primary completion date: Apr 15, 2022 to May 15, 2022
    • Study completion date: Jul 20, 2022 to Oct 20, 2022
    v7
  8. Start date: Dec 28, 2021 to Feb 28, 2022v6
  9. Start date: Nov 1, 2021 to Dec 28, 2021
    • Primary completion date: Nov 15, 2021 to Apr 15, 2022
    • Study completion date: Jan 20, 2022 to Jul 20, 2022
    v5
  10. Start date: Sep 15, 2021 to Nov 1, 2021
    • Study completion date: Dec 20, 2021 to Jan 20, 2022
    v4
  11. Start date: Jul 15, 2021 to Sep 15, 2021
    • Primary completion date: Jul 15, 2021 to Nov 15, 2021
    • Study completion date: Sep 20, 2021 to Dec 20, 2021
    v3
  12. Primary endpoint revised
    • Secondary endpoints revised (3)
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Somatosensory evoked potentials are crucial in determining the physiological changes of potentials in nerve pathways. Although their main function is diagnostic, the investigators have recently been used as a physiological test to determine physioelectric changes in healthy subjects to study applied stimuli, such as laser, pain or electrotherapy.
Trial Details
NCT Number NCT04962737
Lead Sponsor University of Las Palmas de Gran Canaria
Conditions
(from sponsor)		 Healthy Volunteers
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov